{"id":742788,"date":"2023-03-27T08:41:01","date_gmt":"2023-03-27T12:41:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/"},"modified":"2023-03-27T08:41:01","modified_gmt":"2023-03-27T12:41:01","slug":"biosig-announces-new-advisory-board-member-edwin-wang","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/","title":{"rendered":"BioSig Announces New Advisory Board Member Edwin Wang"},"content":{"rendered":"<div class=\"mw_release\">\n<p \/>Westport, CT, March  27, 2023  (GLOBE NEWSWIRE) &#8212;   <\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O61imum4FWs_-1OP8xAlx4cOCWqhhia0m9RZnesQHcC-cY48pKBMMZ4QKzY-lusVvIrCg7sVdbyH3R9OXUaXJusbeEyduG00tf_7uF85PQk=\" rel=\"nofollow noopener\" target=\"_blank\">BioSig Technologies, Inc.<\/a> (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP\u2122 System, today announced the appointment of new Advisory Board member Edwin Wang. <\/p>\n<p>Mr. Wang has over 20 years of impactful experience in private equity, venture capital, merchant banking, and family office investing. He is the founder of Accretive Capital Partners LLC, a pioneering direct investment sponsor in middle market private equity that raised, invested and harvested a top quartile secondary direct investment fund, Accretive Exit Capital Partners LP, with seasoned limited partners HarbourVest Partners, Goldman Sachs Vintage Funds, and Paul Capital Partners. Accretive Capital Partners has advised in excess of $2 billion in portfolio and fund restructurings.<\/p>\n<p>Earlier, while at predecessor affiliate Asymmetry Capital LLC, Mr. Wang led the successful financial restructuring and liquidation of $1 billion in venture capital portfolios from Zero Stage Capital whose legacy spawned a forerunner to Moderna. These accomplishments were chronicled in several Harvard Business School case studies and other publications, including The Deal Magazine. Previously, following an eight-year investment banking career at Credit Suisse and Lehman Brothers, he led the formation of Asia Corporate Partners Fund, among the very first institutional direct investment fund products for China anchored by CalPERS, CalSTRS, Capital Group, China Development Bank (Taiwan), (whose core holdings included Hon Hai Precision (Foxconn), Taiwan Semiconductor Manufacturing and Texas Instruments\/Acer) along with other leading global asset managers. <\/p>\n<p>Mr. Wang earned his B.A. in Economics from Columbia University and was a Visiting Fellow in Finance at the MIT Sloan School of Management at the invitation of the late Nobel laureate in Economics, Dr. Franco Modigliani. <\/p>\n<p>\u201cEdwin Wang is a highly regarded and well-connected investment strategist with many years of experience in global capital markets, including a storied record of success in private equity growth capital and technology investing,\u201d said Ken Londoner, Chairman, CEO and Founder of BioSig. \u201cHe will be an excellent resource for our capital markets strategy and targeted expansion of our shareholder base. We warmly welcome Ed to our advisory team.\u201d<\/p>\n<p>\u00a0\u201cKen Londoner is a seasoned entrepreneur who blends strategic vision, technical brilliance and solid execution \u2013 a rare combination in the intersection of finance and industry \u2013 and I am excited to help support him and the team at BioSig \u201c said Edwin Wang\u00a0 \u201cOver the past quarter century, I have made numerous investments in technology enabled healthcare companies, several of which have had a profound impact on medicine and public health.\u00a0 (Cardiovascular disease has been the leading cause of death for too long with annual direct costs in the U.S. alone estimated to be $109B*.)\u00a0 BioSig Technologies leads the way forward in digital signal processing and AI for the treatment of cardiac arrhythmias.\u00a0 I am humbled to be a part of this critical mission to improve patient outcomes and save lives!\u201d<\/p>\n<p>* Benjamin\u00a0EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association.\u00a0<em>Circulation<\/em>. 2018;137:e67\u2013e492.<\/p>\n<p>\u00a0<\/p>\n<p><em>Edwin Wang <\/em><\/p>\n<p><strong>About BioSig Technologies<\/strong><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O61imum4FWs_-1OP8xAlxy__nLhnGa-8CJmjUt_uHPZTl0Cwa-xVeEkaGgJRS3Mrev3oVDnXdnV7-Vf7JobfgmiqEcGeDuF--qLhc_640dU=\" rel=\"nofollow noopener\" target=\"_blank\">BioSig Technologies<\/a> is an advanced digital signal processing technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), BioSig is committed to addressing healthcare\u2019s biggest priorities \u2014 saving time, saving costs, and saving lives.<\/p>\n<p>The Company\u2019s first product, the PURE EP\u2122 System, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy.<\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vR5Vvt4pjwKPSfexpyaIHIC7YqYggD_slp2UBUij9Z7P-yXRmrsTe_5C0rCz76fT76_rVIa8l59bAPYo94lIm_6ngGrjHJCHQ4Hw-nzthaIZ69gPXq9AdhxBmQ9VUrg9\" rel=\"nofollow noopener\" target=\"_blank\">The PURE EP\u2122 System<\/a> is currently in a national commercial launch and an integral part of well-respected healthcare systems, such as Mayo Clinic, Texas Cardiac Arrhythmia Institute, Cleveland Clinic, and Kansas City Heart Rhythm Institute. In a\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8RV_0uRtca5u9-6aZSoPFLpxYebTMEAH_8mOF67_NCDdivwxJSilW1a39PPLrjUwVC64y4-OrPENtkTVr9TQR-sjmvRVD7onNmhlAVppuBln_yNzyr5nv-zlEhfnXMyxNPrxnbx3MeyvBCngg2iF5lPtS_TN7yfCXPxXxKVl_EIq_mkxSiP8THIQBNCbvj92VGer6M2wVrwEHnpceGpbXjUVLyd5o45IcXs6hmDbP7321uovY0iBpnVYYQZOEQBevdlvqBOkbtczGMaK6h2hbvezpsUiZlgfMlXNUF9f4BF2icIWjmExvMxN4pOHzKLG\" rel=\"nofollow noopener\" target=\"_blank\">blinded clinical study<\/a>\u00a0recently published in the Journal of Cardiovascular Electrophysiology, electrophysiologists rated PURE EP\u2122 as equivalent or superior to conventional systems for 93.6% of signal samples, with 75.2% earning a superior rating.<\/p>\n<p>The global EP market is projected to reach $16B in 2028 with an 11.2% growth rate.<sup>1<\/sup><\/p>\n<p><strong>Forward-looking Statements<\/strong><br \/> This press release contains &#8220;forward-looking statements.&#8221; Such statements may be preceded by the words &#8220;intends,&#8221; \u201cmay,\u201d \u201cwill,\u201d \u201cplans,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cprojects,\u201d \u201cpredicts,\u201d \u201cestimates,\u201d \u201caims,\u201d \u201cbelieves,\u201d \u201chopes,\u201d \u201cpotential\u201d or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company\u2019s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company\u2019s filings with the Securities and Exchange Commission (SEC), including the Company\u2019s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9LXvj5gkfYG51zim1l9Qxv5VZVFzlUXk4fBRu-RjFNcFdiJ59I0ihNSZos8vlw6LZcDHBnswcvNR5eiEaVgjBM1LBq3G2eN3aqsj8fter8Hn18Ek46NwDgqNxvLmkRLoX9KDXVrrwo_duQq1yL8-_JiRyzuNp7GSB3guXmb9Ew5xn2EZQwWiIg1TqxB_jAHeXTNGCCjsHzyJPSv1H35SQftXqlRviYJTT7NowAp5r-EoiHBgHA2X0bv-FtDeYWAKZT3ccjQ9tYu3u4UdedHgiKcyWDHk1kNwuvqkHmWJ6QP2K9rhAkpj3fSVbNbXHyvYLSWwz69JGPncEunlzQDVmHBhfZbdf1L0dIh4FlRW4Npp-lRWZrJUScd4GkSg2kUeB0uxIYKl9MoDIg3cZnaK1di4DJY7amJfzI78x4xpJ66NGmHumpGbUk73y-4lBS7gPs-bKlcpPlBSnBjPIrCiQx2vQTIF5ls630i53UE5RIpSxmdsRj0NVd3NdXPJPNQgUTX4zuz8Me5UaxJ1P2QRjEbg0JjpfWvalcDb9ZQSuaz4IUcd6Nt056OqXahld5dfVcKEmbSm3AAQ62qtqF5ykWvzuGn3dVqSCLDTBwlrvUe5VcFn1EzgqGeKUPQiYNs3ZUFQ4erIVOFZ1anVWtxoCGhiJWP83bwSapyo6PIaBU4GHrNaN4igJGHUnDN1EiuGr-iHjGoKXaj7SyLD6JdDYuRShKtPqyOXB3QP-6JeNdhVSol4hZtckP_OxvpMI-4a6L6I5zgaSqVC3-rEKZHjRNJmbKeKAQzaIOLYpoobs6kYahE-miSIkMWjqq7PeH0s-10Eksh0fcARGiifvD79LvupmEuS7E3WVIfxpHIRhAMW4Bu81e2K4OF4TymQw-e71xDLXfK-0RK9fhB8op5siaNjzOpG0mYp1TwA3R0lTvrH_lAC0fjOnG7jYsnnpUwC9n-_CIMmynUmjE1aQaeUJGmLHXLXKfTAoHTM-9srAaOlrM5u0bVILDZn4T7DK_Uz\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.sec.gov<\/a>. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.<\/p>\n<hr \/>\n<p><sup>1<\/sup> Global Market Insights Inc. March 08, 2022. <\/p>\n<p><\/p>\n<p><img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=\" \/><br \/><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YmQyYTUzM2QtN2Q0Yi00NjQwLWE4NDYtOTA4N2E0OGU3YzM0LTEwMjk2NDk=\/tiny\/BioSig-Technologies-Inc-.png\" \/><\/div>\n<div class=\"mw_contactinfo\">\n<pre>Andrew Ballou\r\nBioSig Technologies, Inc.\r\nVice President, Investor Relations\r\n55 Greens Farms Road, 1st Floor\r\nWestport, CT 06880\r\naballou@biosigtech.com\r\n203-409-5444, x133\r\n\r\n\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP\u2122 System, today announced the appointment of new Advisory Board member Edwin Wang. Mr. Wang has over 20 years of impactful experience in private equity, venture capital, merchant banking, and family office investing. He is the founder of Accretive Capital Partners LLC, a pioneering direct investment sponsor in middle market private equity that raised, invested and harvested a top quartile secondary direct investment fund, Accretive Exit Capital Partners LP, with seasoned limited partners HarbourVest Partners, Goldman Sachs Vintage Funds, and Paul Capital Partners. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioSig Announces New Advisory Board Member Edwin Wang&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-742788","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioSig Announces New Advisory Board Member Edwin Wang - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioSig Announces New Advisory Board Member Edwin Wang - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP\u2122 System, today announced the appointment of new Advisory Board member Edwin Wang. Mr. Wang has over 20 years of impactful experience in private equity, venture capital, merchant banking, and family office investing. He is the founder of Accretive Capital Partners LLC, a pioneering direct investment sponsor in middle market private equity that raised, invested and harvested a top quartile secondary direct investment fund, Accretive Exit Capital Partners LP, with seasoned limited partners HarbourVest Partners, Goldman Sachs Vintage Funds, and Paul Capital Partners. &hellip; Continue reading &quot;BioSig Announces New Advisory Board Member Edwin Wang&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T12:41:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioSig Announces New Advisory Board Member Edwin Wang\",\"datePublished\":\"2023-03-27T12:41:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/\"},\"wordCount\":980,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/\",\"name\":\"BioSig Announces New Advisory Board Member Edwin Wang - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=\",\"datePublished\":\"2023-03-27T12:41:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-announces-new-advisory-board-member-edwin-wang\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioSig Announces New Advisory Board Member Edwin Wang\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioSig Announces New Advisory Board Member Edwin Wang - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/","og_locale":"en_US","og_type":"article","og_title":"BioSig Announces New Advisory Board Member Edwin Wang - Market Newsdesk","og_description":"Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP\u2122 System, today announced the appointment of new Advisory Board member Edwin Wang. Mr. Wang has over 20 years of impactful experience in private equity, venture capital, merchant banking, and family office investing. He is the founder of Accretive Capital Partners LLC, a pioneering direct investment sponsor in middle market private equity that raised, invested and harvested a top quartile secondary direct investment fund, Accretive Exit Capital Partners LP, with seasoned limited partners HarbourVest Partners, Goldman Sachs Vintage Funds, and Paul Capital Partners. &hellip; Continue reading \"BioSig Announces New Advisory Board Member Edwin Wang\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-27T12:41:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioSig Announces New Advisory Board Member Edwin Wang","datePublished":"2023-03-27T12:41:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/"},"wordCount":980,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/","name":"BioSig Announces New Advisory Board Member Edwin Wang - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=","datePublished":"2023-03-27T12:41:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NTk5MSM1NDkzMzMxIzIwMTgwNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-announces-new-advisory-board-member-edwin-wang\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioSig Announces New Advisory Board Member Edwin Wang"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=742788"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742788\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=742788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=742788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=742788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}